Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: MIST) Delayed: 0.80 +0.04 (5.26%)
Previous Close $0.76    52 Week High $ 
Open $0.78    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.74    EPS $ 
Volume 725,573